OBJECTIVE: This study was undertaken to compare the rate of abnormal glucos
e levels measured after 1 hour (> 140 mg%) with those measured after 2 hour
s (> 120 mg%) postprandially in women with gestational diabetes mellitus (G
DM).
STUDY DESIGN: Sixty-eight women were included in this study. All had GDM ba
sed on the criteria of Carpenter-Coustan. Women with fasting glucose levels
of 105 mg% or more were excluded from the study. All women were initially
treated by diet. All women measured daily capillary blood glucose levels wh
en fasting as well as 1 hour and 2 hours postprandially for 1 week, immedia
tely after diagnosis of GDM. Glucose levels were obtained by memory-based g
lucometers. All women were followed in a specialized gestational-diabetes c
linic throughout the pregnancy. Insulin therapy was started on an individua
l basis according to common clinical criteria. Epidemiologic and perinatal
data were collected from medical charts.
RESULTS: The average age of the women was 30.8 +/- 5.4 years. Thirty-five p
ercent of participants were primipara. The mean gestational age at diagnosi
s was 28.8 +/- 5.4 weeks. Glucose measurements included 618 readings during
fasting and 2730 either I hour or 2 hours postprandial. Rates of abnormal
glucose (> 95 mg% when fasting; > 140 mg% 1 hour or > 120 mg% 2 hours after
each meal) per person were the following: fasting, 27.1% abnormal glucose
measurements; postbreakfast, 22.4% abnormal levels after 1 and 8.5% after 2
hours (P < .01); postlunch, 16.4% abnormal levels after 1 hour and 18.2% a
fter 2 hours (not significant); postdinner, 16.3% abnormal levels after 1 h
our and 30.1% after 2 hours (P < .01).
CONCLUSION: The rate of abnormal values was 2.5-fold greater 1 hour postbre
akfast than 2 hours postbreakfast, in contrast to an opposite ratio of a 2-
fold increase in the rate of abnormal values 2 hours postdinner versus 1 ho
ur postdinner. Therefore, differential measurement (1 hour after breakfast
and 2 hours after dinner) might impose stricter criteria for controlling bl
ood glucose levels. Further clinical research should explore whether differ
ential measurements might reduce the rate of diabetes-associated complicati
ons.